Citius Pharmaceuticals, Inc. (CTXR)
NASDAQ: CTXR · Real-Time Price · USD
0.8580
+0.0015 (0.18%)
At close: Jan 16, 2026, 4:00 PM EST
0.8475
-0.0105 (-1.22%)
After-hours: Jan 16, 2026, 7:21 PM EST
Citius Pharmaceuticals Market Cap
Citius Pharmaceuticals has a market cap or net worth of $17.81 million as of January 16, 2026. Its market cap has decreased by -42.35% in one year.
Market Cap
17.81M
Enterprise Value
15.38M
1-Year Change
-42.35%
Ranking
Category
Stock Price
$0.86
Market Cap Chart
Since July 6, 2017, Citius Pharmaceuticals's market cap has decreased from $30.70M to $17.81M, a decrease of -41.97%. That is a compound annual growth rate of -6.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 17.80M | 10.56% |
| Dec 31, 2025 | 16.10M | -47.90% |
| Dec 31, 2024 | 30.90M | -74.31% |
| Dec 29, 2023 | 120.30M | 4.16% |
| Dec 30, 2022 | 115.50M | -48.64% |
| Dec 31, 2021 | 224.90M | 296.65% |
| Dec 31, 2020 | 56.70M | 92.20% |
| Dec 31, 2019 | 29.50M | 59.46% |
| Dec 31, 2018 | 18.50M | -42.19% |
| Dec 29, 2017 | 32.00M | 4.23% |
| Jul 6, 2017 | 30.70M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 929.76B |
| Johnson & Johnson | 526.82B |
| AbbVie | 378.84B |
| UnitedHealth Group | 299.85B |
| AstraZeneca | 291.69B |
| Novartis AG | 276.38B |
| Merck & Co. | 270.12B |
| Novo Nordisk | 268.23B |